$0.8030
-0.0174-2.12%
al cierre: Nov 20, 4:00 PM EST

OS Therapies (OSTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $-0.23 | $-0.12 | -91.7 % |
| Q2 | Aug 17, 2026 | $-0.20 | $-0.23 | 13.0 % |
| Q1 | May 18, 2026 | $-0.27 | $-0.19 | -42.1 % |
| Q4 | Mar 31, 2026 | $-0.41 | $-0.16 | -156.3 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $0 | $600.00K | -100.0 % |
| Q2 | Aug 17, 2026 | $0 | $204.40K | -100.0 % |
| Q1 | May 18, 2026 | $0 | $242.75K | -100.0 % |
| Q3 | Nov 17, 2025 | $0 | $27.50M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.23 | $-0.19 | $-0.16 |
| Actual | $-0.23 | $-0.20 | $-0.27 | $-0.41 |
| Surprise | -91.7% | +13.0% | -42.1% | -156.3% |
| Revenue | ||||
| Estimate | $600000 | $204400 | $242750 | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.14 | $-0.08 | $-0.11 | $1.63 |
| Revenue | ||||
| Consensus | $31.0M | $2.9M | — | — |